# OnCo record low-potassium-and-low-phosphate-on-anticancer-drugs (protocol). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/protocols/low-potassium-and-low-phosphate-on-anticancer-drugs/>
  a schema:MedicalGuideline ;
  onco:kind "protocol" ;
  schema:identifier "low-potassium-and-low-phosphate-on-anticancer-drugs" ;
  schema:name "Low potassium and low phosphate on anticancer drugs: monitoring, replacement and dose holds"@en ;
  schema:alternateName "hypokalaemia on cancer treatment"@en, "hypokalemia"@en, "hypophosphataemia on cancer treatment"@en, "hypophosphatemia"@en, "low potassium on abiraterone"@en, "low phosphate on nirogacestat"@en, "potassium on quizartinib"@en, "electrolytes on dinutuximab"@en, "potassium replacement"@en, "phosphate replacement"@en ;
  schema:description "Some cancer medicines lower the potassium or phosphate in the blood. A mild fall usually causes no symptoms, so it is found on blood tests and treated with tablets or a drip. The medicine is paused only when a low level is severe or does not respond. Tell your team about muscle weakness, cramps or pain, palpitations, or diarrhoea or vomiting. Your own team's plan comes first."@en ;
  schema:url <https://onco.cc/protocols/low-potassium-and-low-phosphate-on-anticancer-drugs/> ;
  schema:dateModified "2026-11-18"^^xsd:date ;
  onco:related <https://onco.cc/protocols/qt-prolongation-monitoring-on-anticancer-drugs/>, <https://onco.cc/protocols/hypomagnesaemia-on-egfr-antibodies/>, <https://onco.cc/protocols/hyperphosphataemia-on-fgfr-inhibitors/>, <https://onco.cc/protocols/hyponatraemia-siadh/>, <https://onco.cc/protocols/tumour-lysis-syndrome-prevention-and-treatment/>, <https://onco.cc/protocols/capillary-leak-syndrome-on-anticancer-drugs/>, <https://onco.cc/protocols/treatment-induced-diarrhoea-grading-and-management/> ;
  onco:drugs <https://onco.cc/drugs/quizartinib/>, <https://onco.cc/drugs/nirogacestat/>, <https://onco.cc/drugs/dinutuximab/>, <https://onco.cc/drugs/abiraterone/> ;
  onco:terms <https://onco.cc/terms/qt-prolongation/>, <https://onco.cc/terms/ctcae-grading/> .
